Dr. Eva Feldman to address Michigan Israel Business Bridge Nov. 12 in Grand Rapids

Taubman Institute Director Dr. Eva Feldman will address a special event at the Van Andel Institute in Grand Rapids on Monday, Nov. 12.  The meeting is a special networking luncheon with the Michigan Israel Business Bridge, a non-profit association that promotes economic growth in Michigan and Israel.

Dr. Feldman, the Russell N. DeJong professor of neurology at the University of Michigan and leader of the first-ever stem cell trial in patients with ALS, will tell the groups about her groundbreaking collaboration with another stem cell pioneer, Benjamin E. Reubinoff, M.D., Ph.D., of Hadassah University Hospital in Jerusalem.  Her talk is entitled "U-M and Hadassah: Engineering stem cells to decode a deadly disease."

The luncheon will take place from noon to 1:30 p.m.; registration is required by Nov. 6.  The charge for MIBB members is $30 or $35 for non-members.  For complete details, click here.




Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift


Follow Us / Friend Us

Discovery-driven research that matters


Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding


The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more

Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  


Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster


video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists